Papers

11

Total Citations

327

H-Index

8

About

Koop Bosscha is a leading Dutch surgeon whose research focuses on advancing minimally invasive approaches in hepatopancreatobiliary and colorectal surgery. His major contributions center on rigorous, high-level evidence comparing minimally invasive techniques—including laparoscopic, robotic, and open procedures—for complex operations such as pancreatoduodenectomy, distal pancreatectomy, and liver resection. He has been instrumental in landmark trials like LEOPARD-2 (95 citations), which compared minimally invasive versus open pancreatoduodenectomy, and the AVOID trial (84 citations), a multicentre phase 3 study on indocyanine green fluorescence for bowel perfusion assessment to prevent anastomotic leakage in colorectal surgery. His work also includes nationwide analyses of robotic liver surgery implementation in the Netherlands (41 citations) and pan-European propensity-matched studies on robot-assisted versus laparoscopic pancreatoduodenectomy (20 citations). With over 300 total citations across his most-cited papers, Bosscha’s research has directly shaped clinical guidelines and surgical training programs, demonstrating the safety, feasibility, and oncologic outcomes of minimally invasive techniques. His ongoing leadership in collaborative trials like EUREKA underscores his commitment to improving surgical quality and patient outcomes through innovation and evidence-based practice.

Research Focus

Key Achievements

8
H-Index
11
Papers
327
Total Citations
30
Avg Citations/Paper
🏆 Most Cited Paper
Minimally invasive versus open pancreatoduodenectomy (LEOPARD-2): study protocol for a randomized controlled trial
95 citations · 2018
📈 Most Prolific Year: 2024 (7 Papers)
🤝 Key Collaborators: 203
🏛 Institutions: Amsterdam UMC Location University of Amsterdam, Jeroen Bosch Ziekenhuis

Top Papers

  1. 1
  2. 2
  3. 3
  4. 4
  5. 5
  6. 6
  7. 7
  8. 8
  9. 9
  10. 10

Key Collaborators

Contact & Links

Available for collaboration
Content generated · 13 days ago